NCT07027982

A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

An Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Dong-A ST Co., Ltd. · Industry
• Sex: All
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study will evaluate the pharmacokinetics and safety of Diluted and Undiluted Intravenous DA-5217 in healthy adult subjects.

Conditions

• Healthy Adults

Interventions

Type	Name	Description
DRUG	Diluted Intravenous DA-5217	once a day
DRUG	Undiluted Intravenous DA-5217	once a day

Timeline

• Start date: 2025-07-16
• Primary completion: 2025-08-14
• Completion: 2025-08-14
• First posted: 2025-06-19
• Last updated: 2025-08-22

Locations

1 site across 1 country: South Korea